Search Results - "Cabrera Martín, María N."

Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy by Marín-Jiménez, Juan A., Oliva, Marc, Peinado Martín, Paloma, Cabezas-Camarero, Santiago, Plana Serrahima, Maria, Vázquez Masedo, Gonzalo, Lozano Borbalas, Alicia, Cabrera Martín, María N., Esteve, Anna, Iglesias Moreno, María C., Vilajosana Altamis, Esther, Arribas Hortigüela, Lorena, Taberna Sanz, Miren, Pérez-Segura, Pedro, Mesía, Ricard

“…Objectives Induction chemotherapy (ICT) followed by definitive treatment is an accepted non-surgical approach for locoregionally advanced head and neck…”
Get full text

Response to immunotherapy rechallenge after interval chemotherapy in a patient with head and neck cancer by Cabezas-Camarero, Santiago, Cabrera-Martín, María N, Pérez-Segura, Pedro

“…Patients with metastatic squamous cell cancer of the head and neck (SCCHN) have a poor prognosis, with most patients surviving less than a year. Immunotherapy…”
Get full text

Predictive value of PET-CT for pathological response in stages II and III breast cancer patients following neoadjuvant chemotherapy with docetaxel by García García-Esquinas, Marta A., Arrazola García, Juan, García-Sáenz, José A., Furió-Bacete, V., Fuentes Ferrer, Manuel E., Ortega Candil, Aída, Cabrera Martín, María N., Carreras Delgado, José L.

“…To prospectively study the value of PET-CT with fluorine-18 fluorodeoxyglucose (FDG) to predict neoadjuvant chemotherapy (NAC) response of locoregional disease…”
Get full text

Predictive value of PET-CT for pathological response in stages II and III breast cancer patients following neoadjuvant chemotherapy with docetaxel by García García-Esquinas, Marta A, Arrazola García, Juan, García-Sáenz, José A, Furió-Bacete, V, Fuentes Ferrer, Manuel E, Ortega Candil, Aída, Cabrera Martín, María N, Carreras Delgado, José L

“…Abstract Purpose To prospectively study the value of PET-CT with fluorine-18 fluorodeoxyglucose (FDG) to predict neoadjuvant chemotherapy (NAC) response of…”
Get full text

Theranostics in Nuclear Medicine by Carreras-Delgado, José Luis, Blanes-García, Alba M., Wakfie-Corieh, Cristina G., Cabrera-Martín, María N., Ortega-Candil, Aída, Rodríguez-Rey, Cristina

Get full text

Teragnosis en medicina nuclear by Carreras Delgado, José Luis, Blanes García, Alba M, Wakfie-Corieh, Cristina G, Cabrera Martín, María N, Aída Ortega Candil, Cristina Rodríguez Rey

“…La teragnosis en Medicina Nuclear consiste en emplear moléculas unidas a isótopos radiactivos para el diagnóstico y tratamiento de enfermedades. Esta modalidad…”
Get full text